Oscar Health (NYSE:OSCR) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Oscar Health (NYSE:OSCR) from a sell rating to a hold rating in a report published on Saturday morning.

Several other research firms have also recently issued reports on OSCR. The Goldman Sachs Group started coverage on Oscar Health in a research report on Tuesday, October 14th. They set a “neutral” rating and a $17.00 target price on the stock. Wells Fargo & Company dropped their price objective on Oscar Health from $14.00 to $11.00 and set an “underweight” rating on the stock in a report on Thursday, November 13th. Barclays increased their price objective on Oscar Health from $11.00 to $13.00 and gave the stock an “underweight” rating in a research report on Monday, November 10th. Baird R W lowered shares of Oscar Health from a “strong-buy” rating to a “hold” rating in a research report on Friday, July 25th. Finally, UBS Group upped their price target on shares of Oscar Health from $11.00 to $12.00 and gave the stock a “sell” rating in a research note on Friday, November 7th. Six investment analysts have rated the stock with a Hold rating and five have assigned a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Reduce” and a consensus price target of $13.14.

Oscar Health Stock Performance

Shares of OSCR opened at $16.49 on Friday. The stock has a market capitalization of $4.37 billion, a P/E ratio of -14.73 and a beta of 1.88. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.92 and a current ratio of 0.92. Oscar Health has a 1 year low of $11.20 and a 1 year high of $23.80. The company’s fifty day moving average is $18.22 and its two-hundred day moving average is $16.91.

Oscar Health (NYSE:OSCR) last issued its earnings results on Thursday, November 6th. The company reported ($0.53) earnings per share for the quarter, beating the consensus estimate of ($0.55) by $0.02. Oscar Health had a negative net margin of 2.16% and a negative return on equity of 21.50%. The business had revenue of $2.93 billion for the quarter, compared to the consensus estimate of $3.09 billion. During the same quarter in the previous year, the firm earned ($0.22) earnings per share. The business’s quarterly revenue was up 23.2% compared to the same quarter last year. Oscar Health has set its FY 2025 guidance at EPS. On average, sell-side analysts predict that Oscar Health will post 0.69 earnings per share for the current year.

Insider Activity

In related news, insider Mario Schlosser sold 286,182 shares of the firm’s stock in a transaction on Tuesday, November 11th. The stock was sold at an average price of $15.27, for a total transaction of $4,369,999.14. Following the transaction, the insider directly owned 501,148 shares in the company, valued at $7,652,529.96. This trade represents a 36.35% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 25.11% of the company’s stock.

Institutional Trading of Oscar Health

A number of institutional investors and hedge funds have recently modified their holdings of the business. Vanguard Group Inc. lifted its position in shares of Oscar Health by 2.1% in the 3rd quarter. Vanguard Group Inc. now owns 20,160,399 shares of the company’s stock worth $381,636,000 after buying an additional 423,184 shares during the last quarter. T. Rowe Price Investment Management Inc. raised its stake in Oscar Health by 4.1% during the first quarter. T. Rowe Price Investment Management Inc. now owns 11,826,245 shares of the company’s stock worth $155,043,000 after acquiring an additional 467,301 shares during the period. Thrive Capital Management LLC lifted its holdings in Oscar Health by 33.4% in the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock worth $85,258,000 after acquiring an additional 1,588,395 shares during the last quarter. American Century Companies Inc. boosted its stake in Oscar Health by 89.0% in the third quarter. American Century Companies Inc. now owns 5,298,340 shares of the company’s stock valued at $100,298,000 after acquiring an additional 2,495,691 shares during the period. Finally, BIT Capital GmbH grew its holdings in shares of Oscar Health by 1.1% during the first quarter. BIT Capital GmbH now owns 4,521,445 shares of the company’s stock valued at $59,276,000 after purchasing an additional 47,592 shares during the last quarter. 75.70% of the stock is owned by institutional investors and hedge funds.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.